Description: The presenters will dig into the little rider that most actuaries don't spend much time thinking about. A regulator, a direct writer and a consultant will discuss their thoughts on this rider and point out areas where actuaries should focus before deeming it insignificant. Topics will include the current study underway to update the industry experience study (most recently done in 1952), underwriting considerations, interactions with other riders, benefit designs, unique issues on UL policies, tax implications and reserving considerations

Description: How do combo products fit in the new statutory valuation framework?

Description: Designing and Pricing LTCI Combination Products by Carl L. Friedrich from Long-Term Care Newsletter, December 2004, Issue No. 13.

Description: This article is a transcript of a session at the Spring 1975 Meeting in Los Angeles. It addresses the question of whether traditional valuation principles can provide the same assurance of company solvency as in the past. Discussions include: Generally Accepted Accounting Principles GAAP, impact of changing asset values on cash flow and surplus problems.

Description: This article highlights features of the SOA's Regulatory Web Resource. The intent is to encourage greater use of the Resource among section members.

Description: Key considerations when modeling reinsurance to calculate reserves under PBR as well as a case study examining the impact of reinsurance structures on reserves.

Description: 1998 Valuation Actuary Symposium. This session about strengthening reserves based on cash-flow testing provided some practical solutions to reserve-strengthening issues using reinsurance and a look at the issue from a small company perspective.

Description: This session at the SOA 1990 San Francisco Spring Meeting focuses on AIDS including an update on the epidemic and discussion about the actuarial implication of four case studies.

Description: Illustrates key differences, in earnings for a segment of term insurance, between current GAAP standards and GAAP targeted improvements (based on tentative board decisions preceding the release of an exposure draft).

Description: In-depth discussion about HIV and AIDS: [1] mortality-study results, [2] risk-classification challenges, including regulatory issues, [3] mortality-projection methods, [4] significant pricing and valuation – STAT and GAAP – information, and [5] overall industry implications. From the 1988 Record of Society of Actuaries, Vol. 14, No. 4A.